Filing Details
Aptevo Therapeutics Inc. (NASDAQ:APVO) filed a Form 8-K with the Securities and Exchange Commission on August 14, 2026, disclosing a material event.
8k filedNASDAQ:APVO
Aptevo Therapeutics Inc. (APVO) Reports Material Event to SEC
Aptevo Therapeutics Inc. (NASDAQ:APVO) filed a Form 8-K with the Securities and Exchange Commission on August 14, 2026, disclosing a material event.
At publication ·
What changed
Aptevo Therapeutics Inc. (NASDAQ:APVO) · 8k filed
- Form
- 8-K
At a glance
Key takeaways
- Aptevo Therapeutics Inc. (NASDAQ:APVO) filed a Form 8-K with the SEC on August 14, 2026, disclosing a material event that shareholders should be aware of.
- The company's stock trades at $2.94 with a market capitalization of $12.0 million.
- The article does not specify the nature of the material event, which could involve leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance.
Market Context
Aptevo Therapeutics Inc.'s stock currently trades at $2.94 with a market capitalization of $12.0M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Aptevo Therapeutics Inc.'s stock.
All SEC filings for Aptevo Therapeutics Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View APVO Stock Page
Frequently Asked Questions
Where can I read APVO's SEC filings?
Browse all filings on our APVO SEC filings page.
What types of SEC filings does Aptevo Therapeutics Inc. file?
Public companies like Aptevo Therapeutics Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.